Xtandi 欧盟 - 丹麦文 - EMA (European Medicines Agency)

xtandi

astellas pharma europe b.v. - enzalutamide - prostatiske neoplasmer - endokrine terapi - xtandi is indicated for:the treatment of adult men with metastatic hormone-sensitive prostate cancer (mhspc) in combination with androgen deprivation therapy (see section 5. the treatment of adult men with high-risk non-metastatic castration-resistant prostate cancer (crpc) (see section 5. the treatment of adult men with metastatic crpc who are asymptomatic or mildly symptomatic after failure of androgen deprivation therapy in whom chemotherapy is not yet clinically indicated (see section 5. the treatment of adult men with metastatic crpc whose disease has progressed on or after docetaxel therapy.

Orfiril 100 mg/ml injektionsvæske, opløsning 丹麦 - 丹麦文 - Lægemiddelstyrelsen (Danish Medicines Agency)

orfiril 100 mg/ml injektionsvæske, opløsning

desitin arzneimittel gmbh - natriumvalproat - injektionsvæske, opløsning - 100 mg/ml

Orfiril Long 150 mg depotkapsler, hårde 丹麦 - 丹麦文 - Lægemiddelstyrelsen (Danish Medicines Agency)

orfiril long 150 mg depotkapsler, hårde

desitin arzneimittel gmbh - natriumvalproat - depotkapsler, hårde - 150 mg